Stocks › CI
Cigna Group
CI·NYSE·
United States·USD
United States·USD$271.29
+0.76 (+0.28%)
Close · Oct 5, 2026 · Close Prices from Tiingo.com
CI
Cigna Group · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CIS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CI by members of U.S. Congress · 149 on record · 26 in the last 12 months
Whale Activity
Position changes in CI reported for 2026-09-30 by 1 tracked institutional filer
- Increased0
- New0
- Held0
- Decreased1
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| HALL LAURIE J TRUSTEE | 12.2K | $3.3M | decreased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CI insiders, by quarter · Form 4
Recent Insider Transactions
2,966 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Neville EverettSee Remarks | Sale | −617 | $284.05 | $175K | Sep 3, 2026 | Form 4 ↗ |
| Jones Nicole SSee Remarks | Sale | −2,677 | $279.61 | $749K | Aug 18, 2026 | Form 4 ↗ |
| Jones Nicole SSee Remarks | Sale | −19.4K | $276.27 | $5.4M | Aug 4, 2026 | Form 4 ↗ |
| Kates Jamie GChief Accounting Officer | Sale | −899 | $298.61 | $268K | Jun 12, 2026 | Form 4 ↗ |
| Kates Jamie GChief Accounting Officer | Option exercise | +899 | $152.89 | $137K | Jun 12, 2026 | Form 4 ↗ |
| Koka Durga PrasadEVP, Global CIO | Tax withholding | −729 | $275.53 | $201K | Jun 1, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Option exercise | +7,971 | $197.35 | $1.6M | May 13, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Option exercise | +15.5K | $149.14 | $2.3M | May 13, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Sale | −2,231 | $298.53 | $666K | May 12, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Sale | −15.3K | $298.24 | $4.6M | May 12, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Sale | −2,017 | $296.84 | $599K | May 12, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Sale | −34.6K | $295.98 | $10.3M | May 12, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Sale | −38.5K | $294.98 | $11.4M | May 12, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Sale | −2,142 | $293.92 | $630K | May 12, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Sale | −7,861 | $292.88 | $2.3M | May 12, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Sale | −12.3K | $291.95 | $3.6M | May 12, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Sale | −13.7K | $291.01 | $4.0M | May 12, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Sale | −41.1K | $290.00 | $11.9M | May 12, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Sale | −13.8K | $288.85 | $4.0M | May 12, 2026 | Form 4 ↗ |
| Cordani DavidChairman & CEO · Director | Sale | −14.3K | $287.96 | $4.1M | May 12, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CI · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 8.4M | $2.32B | 0.10% | Jun 30, 2026 |
| Dodge & Cox Stock Fund Dodge & Cox Funds | 8.0M | $2.20B | 1.86% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 6.9M | $1.89B | 0.11% | Jun 30, 2026 |
| MFS Value Fund MFS SERIES TRUST I | 5.2M | $1.43B | 2.80% | May 31, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 3.6M | $1.00B | 0.11% | Jun 30, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 3.4M | $935.3M | 0.11% | May 31, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 3.2M | $883.8M | 0.11% | Jun 30, 2026 |
| VANGUARD WINDSOR II FUND VANGUARD WINDSOR FUNDS | 2.9M | $799.9M | 1.20% | Jul 31, 2026 |
| VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS | 2.5M | $694.4M | 0.27% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF SELECT SECTOR SPDR TRUST | 1.9M | $515.2M | 1.27% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list CI's shares (CUSIP 125523100), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming cigna as client
- BANNER PUBLIC AFFAIRS, LLCTHE CIGNA GROUP AND SUBSIDIARIES (FKA CIGNA CORPORATION AND SUBSIDIARIES) · 2026 Q2 · DEF, HCR$20K
Filing ↗ - CAPITOL HILL CONSULTING GROUPCIGNA · 2026 Q2 · DEF, HCR$50K
Filing ↗ - THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) · 2026 Q2 · MMM, PHA, DEF, HCR$2.1M
Filing ↗ - ATLAS CROSSING LLCTHE CIGNA GROUP AND SUBSIDIARIES · 2026 Q2 · HCR$60K
Filing ↗ - POLARIS GOVERNMENT RELATIONS, LLCCIGNA CORPORATION · 2026 Q2 · HCR, PHA$90K
Filing ↗
Government Contracts
Federal awards to Cigna Group · USAspending
No federal contract awards found for Cigna Group.
U.S. Patents
Recent USPTO applications naming Cigna Group
No USPTO patent applications found for Cigna Group.
Annual Financials
From CI's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| Operating income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B |
| Net income | $5.96B | $3.43B | $5.16B | n/a | n/a |
| Diluted EPS | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 |
| Operating cash flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B |
| Cash and equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B |
| Total assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B |
| Total liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B |
| Shareholders' equity | $41.71B | $41.03B | $46.22B | $44.67B | $47.11B |
As Cigna Group tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 26, 2026 ↗
Stock Splits
Every split and reverse split in the price history
- 3-for-1Stock splitJun 5, 2007
- 3-for-1Stock splitMay 18, 1998
Split dates and ratios from the price history · Close Prices from Tiingo.com
About Cigna Group
From SEC EDGAR company records
Industry (SIC 6324)Hospital & Medical Service Plans
SectorFinancials
HeadquartersBLOOMFIELD, CT
IncorporatedDE
SEC CIK0001739940 ↗
Former namesCigna Corp, Halfmoon Parent, Inc.